{"id":62352,"date":"2025-12-13T07:07:06","date_gmt":"2025-12-13T06:07:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/"},"modified":"2025-12-13T07:07:06","modified_gmt":"2025-12-13T06:07:06","slug":"sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/","title":{"rendered":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares"},"content":{"rendered":"<div>\n<p>\n<i>Strategic acquisition strengthens SBC&#8217;s comprehensive service offerings and R&amp;D capabilities<\/i>\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/5\/SBC_logo_H_Gray_%286%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/5\/SBC_logo_H_Gray_%286%29.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/21\/SBC_logo_H_Gray_%286%29.jpg\"><\/a><\/p>\n<p>TOKYO&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/Healthcare?src=hash\" target=\"_blank\">#Healthcare<\/a>&#8211;SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (\u201cSBC Medical\u201d or the \u201cCompany\u201d), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the &#8220;Tender Offer&#8221;), a medical research and development company specializing in regenerative medicine technologies, listed on the Tokyo Stock Exchange Growth Market.\n<\/p>\n<p>\nThe tender offer, which commenced on November 14, 2025 and concluded on December 12, 2025, was conducted at JPY 1,900 per share. Through the Tender Offer, SBC Medical will acquire 575,052 common shares of Waqoo, Inc., with settlement scheduled to commence on December 19, 2025. In addition, Yoshiyuki Aikawa, the largest shareholder of Waqoo, Inc., is expected to transfer all of his remaining shares to SBC Medical through an off-market transaction outside of the Tender Offer, also effective as of December 19, 2025. As a result of these transactions, SBC Medical\u2019s ownership ratio of the voting rights of Waqoo, Inc. is expected to exceed 50% as of the settlement date, and SBC Medical will newly become the parent company and the largest shareholder of Waqoo, Inc. The acquisition aligns with SBC Medical\u2019s strategic expansion and will enhance the Company\u2019s ability to deliver comprehensive solutions to its medical practice clients.\n<\/p>\n<p>\n<b>Transaction Highlights<\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTotal Investment: Approximately JPY 1,092.5 million for up to 575,052 shares\n<\/li>\n<li>\nOffer Price: JPY 1,900 per share\n<\/li>\n<li>\nStrategic Rationale: Expands SBC&#8217;s healthcare technology capabilities and strengthens presence in the Japanese market\n<\/li>\n<\/ul>\n<p>\n<b>1. Overview of the Tender Offer<\/b>\n<\/p>\n<p>\n(1) Name and Address of the Tender Offeror\n<\/p>\n<p>\nSBC Medical Group Co., Ltd.<br \/>\n<br \/>908 Kamikurata-cho, Totsuka-ku, Yokohama, Kanagawa, Japan\n<\/p>\n<p>\n(2) Name of the Target Company\n<\/p>\n<p>\nWaqoo, Inc.\n<\/p>\n<p>\n(3) Type of Securities to Be Purchased\n<\/p>\n<p>\nCommon shares\n<\/p>\n<p>\n(4) Number of Shares Planned to Be Purchased\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nPlanned Purchase Volume\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nMinimum\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nMaximum\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n575,000 shares\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n575,000 shares\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\nIf the total number of tendered shares does not exceed the maximum planned purchase volume of 575,000 shares, all tendered shares will be purchased. If the total number exceeds the maximum, shares will be purchased on a pro rata basis, and the remainder will not be purchased.\n<\/p>\n<p>\n(5) Tender Offer Period\n<\/p>\n<p>\nFrom November 14, 2025 to December 12, 2025 (20 business days)<br \/>\n<br \/>No extension of the tender offer period by the Target occurred.\n<\/p>\n<p>\n(6) Tender Offer Price\n<\/p>\n<p>\nJPY 1,900 per common share\n<\/p>\n<p>\n<b>2. Results of the Tender Offer<\/b>\n<\/p>\n<p>\n(1) Tender Offer Completion\n<\/p>\n<p>\nAs the total number of tendered shares exceeded the maximum planned purchase volume of 575,000 shares, the Tender Offeror will purchase shares on a pro rata basis in accordance with applicable regulations, and shares tendered in excess of such allocation will not be purchased.\n<\/p>\n<p>\n(2) Date and Method of Public Announcement\n<\/p>\n<p>\nThe results of the Tender Offer were publicly announced on December 13, 2025 through the Tokyo Stock Exchange\u2019s disclosure system.\n<\/p>\n<p>\n(3) Number of Shares Tendered and Purchased\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nType of Securities\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTendered (share-equivalent)\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nPurchased (share-equivalent)\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nShares\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n637,817 shares\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n575,052 shares\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nShare Options\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nBonds with Share Acquisition Rights\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nBeneficiary Certificates of Share Trusts\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nDepositary Receipts\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTotal\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n637,817 shares\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n575,052 shares\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n(4) Shareholding Ratio Before and After the Tender Offer\n<\/p>\n<table cellspacing=\"0\" class=\"bwtablemarginb bwblockalignl\">\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\"><\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nVoting Rights\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nOwnership Ratio\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTender Offeror (before)\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n3,536\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n9.49%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nSpecial Related Parties (before)\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n9,898\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n26.58%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTender Offeror (after)\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwalignl bwpadr0 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n9,286\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwalignl bwpadr0 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n24.93%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nSpecial Related Parties (after)\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwalignl bwpadr0 bwvertalignb\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n9,898\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\n26.58%\n<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"bwpadl0\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin\">\nTotal Voting Rights of Target\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n35,977\n<\/p>\n<\/td>\n<td colspan=\"1\" rowspan=\"1\">\u00a0<\/td>\n<td class=\"bwpadl0 bwpadr0 bwvertalignb bwalignl\" colspan=\"1\" rowspan=\"1\">\n<p class=\"bwcellpmargin bwalignl\">\n\u2014\n<\/p>\n<\/td>\n<\/tr>\n<\/table>\n<p>\n(Note: Ownership ratios are calculated based on outstanding shares including potential shares as of the reference date, and rounded to the nearest 0.01%.)\n<\/p>\n<p>\n(5) Pro Rata Allocation Method\n<\/p>\n<p>\nAs the total number of tendered shares exceeded 575,000 shares, shares will be purchased on a pro rata basis. Fractional adjustments were made as required to ensure that the final number of shares purchased does not exceed the maximum purchase volume. In cases where adjustments alone were insufficient, a lottery was conducted among shareholders with equal fractional rounding differences.\n<\/p>\n<p>\n(6) Settlement Method\n<\/p>\n<p>\nTender Offer Agent:<br \/>\n<br \/>SBI Securities Co., Ltd.<br \/>\n<br \/>1-6-1 Roppongi, Minato-ku, Tokyo\n<\/p>\n<p>\nNotification of purchase results will be mailed promptly after the end of the tender offer period. Settlement will be made in cash and remitted to the bank account designated by each tendering shareholder beginning on December 19, 2025.\n<\/p>\n<p>\n<b>3. Policies After Completion of the Tender Offer and Outlook<\/b>\n<\/p>\n<p>\nThere are no changes to the policies and statements previously disclosed in the tender offer registration statement filed on November 14, 2025.\n<\/p>\n<p>\n<b>4. Location of Copies of the Tender Offer Report for Public Inspection<\/b>\n<\/p>\n<p>\nSBC Medical Group Co., Ltd.<br \/>\n<br \/>908 Kamikurata-cho, Totsuka-ku, Yokohama, Kanagawa, Japan\n<\/p>\n<p>\nTokyo Stock Exchange, Inc.<br \/>\n<br \/>2-1 Nihonbashi Kabutocho, Chuo-ku, Tokyo, Japan\n<\/p>\n<p>\n<b>About SBC Medical Group Holdings Incorporated<\/b>\n<\/p>\n<p>\nSBC Medical Group Holdings Incorporated is a comprehensive medical group operating a wide range of franchise businesses across diverse medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, AGA (hair restoration), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000\u00ae Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose \u201cContributing to the well-being of people around the world through medical innovation,\u201d SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.\n<\/p>\n<p>\nFor more information, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsbc-holdings.com%2F&amp;esheet=54373385&amp;newsitemid=20251213679885&amp;lan=en-US&amp;anchor=https%3A%2F%2Fsbc-holdings.com%2F&amp;index=1&amp;md5=b6f0178316c49922f9f2081026481fce\" rel=\"nofollow\" shape=\"rect\">https:\/\/sbc-holdings.com\/<\/a>\n<\/p>\n<p>\n<b>Forward Looking Statements<\/b>\n<\/p>\n<p>\nThis press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company\u2019s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company\u2019s control. These forward-looking statements reflect the Company\u2019s current views with respect to, among other things, the Tender Offer, the Company\u2019s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as \u201cmay,\u201d \u201cshould,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201ccontemplates,\u201d \u201cestimates,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201cprojected,\u201d \u201cpredicts,\u201d \u201cpotential,\u201d \u201ctargets\u201d or \u201chopes\u201d or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management\u2019s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading \u201cRisk Factors\u201d and elsewhere in the Company\u2019s filings with the U.S. Securities and Exchange Commission (the \u201cSEC\u201d), which are accessible on the SEC\u2019s website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54373385&amp;newsitemid=20251213679885&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=2&amp;md5=0db7328b9012e3602b424973f6abb6bf\" rel=\"nofollow\" shape=\"rect\">www.sec.gov<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nSBC Medical Group Holdings Incorporated<br \/>\n<br \/>Hikaru Fukui \/ Head of Investor Relations E-mail: <a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;&#116;o&#x3a;&#x69;&#x72;&#64;&#115;bc&#x2d;&#x68;&#x6f;&#108;&#100;i&#x6e;&#x67;&#x73;&#46;&#99;&#111;m\" rel=\"nofollow\" shape=\"rect\">&#105;r&#x40;s&#x62;c&#x2d;h&#x6f;&#108;&#x64;&#105;&#x6e;&#103;&#x73;&#46;c&#111;m<\/a>\n<\/p>\n<p>\nICR LLC (US time)<br \/>\n<br \/>Bill Zima \/ Managing Partner Email: <a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#108;&#116;&#111;:b&#x69;&#x6c;&#x6c;&#x2e;&#122;&#105;ma&#x40;&#x69;&#x63;&#x72;&#105;&#110;c&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow\" shape=\"rect\">bill&#46;&#122;&#105;&#109;&#97;&#x40;&#x69;&#x63;&#x72;&#x69;&#x6e;&#x63;&#46;com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Strategic acquisition strengthens SBC&#8217;s comprehensive service offerings and R&amp;D capabilities TOKYO&#8211;(BUSINESS WIRE)&#8211;#Healthcare&#8211;SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (\u201cSBC Medical\u201d or the \u201cCompany\u201d), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the &#8220;Tender Offer&#8221;), a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62352","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Strategic acquisition strengthens SBC&#8217;s comprehensive service offerings and R&amp;D capabilities TOKYO&#8211;(BUSINESS WIRE)&#8211;#Healthcare&#8211;SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (\u201cSBC Medical\u201d or the \u201cCompany\u201d), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the &#8220;Tender Offer&#8221;), a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-13T06:07:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares\",\"datePublished\":\"2025-12-13T06:07:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/\"},\"wordCount\":1219,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251213679885\\\/en\\\/2666666\\\/22\\\/SBC_logo_H_Gray_%286%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/\",\"name\":\"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251213679885\\\/en\\\/2666666\\\/22\\\/SBC_logo_H_Gray_%286%29.jpg\",\"datePublished\":\"2025-12-13T06:07:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251213679885\\\/en\\\/2666666\\\/22\\\/SBC_logo_H_Gray_%286%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251213679885\\\/en\\\/2666666\\\/22\\\/SBC_logo_H_Gray_%286%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/","og_locale":"en_US","og_type":"article","og_title":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend","og_description":"Strategic acquisition strengthens SBC&#8217;s comprehensive service offerings and R&amp;D capabilities TOKYO&#8211;(BUSINESS WIRE)&#8211;#Healthcare&#8211;SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (\u201cSBC Medical\u201d or the \u201cCompany\u201d), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the &#8220;Tender Offer&#8221;), a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/","og_site_name":"Pharma Trend","article_published_time":"2025-12-13T06:07:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares","datePublished":"2025-12-13T06:07:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/"},"wordCount":1219,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/","url":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/","name":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg","datePublished":"2025-12-13T06:07:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251213679885\/en\/2666666\/22\/SBC_logo_H_Gray_%286%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sbc-medical-group-holdings-announcement-of-final-results-of-tender-offer-for-waqoo-inc-shares\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62352"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62352\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}